Trial comparisons11

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

1 to 11 of 11

Comparison	Source
Ivabradine vs Placebo: Hospitalisation for Worsening Heart Failure	Trial comparisons
Ivabradine vs Placebo: Primary Composite Endpoint: First Event Among Cardiovascular Death (Including Death of Unknown Cause) or Hospitalization for Worsening Heart Failure.	Trial comparisons
Ivabradine vs Placebo: Unplanned Hospitalisation for CV Reason	Trial comparisons
Ivabradine vs Placebo: Death From Heart Failure	Trial comparisons
Ivabradine vs Placebo: Hospitalisation for Cardiovascular Reason	Trial comparisons
Ivabradine vs Placebo: Hospitalisation for Any Cause	Trial comparisons
Ivabradine vs Placebo: Secondary Composite Endpoint	Trial comparisons
Ivabradine vs Placebo: Cardiovascular Death	Trial comparisons
Ivabradine vs Placebo: All-cause Mortality	Trial comparisons
Ivabradine vs Placebo: Unplanned Hospitalisation for Any Cause	Trial comparisons
Ivabradine vs Placebo: serious adverse events	Trial comparisons

trials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02441218/comparisons